SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : FDC Ltd

BSE: 531599 NSE: FDC ISIN: INE258B01022
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does FDC Ltd belong to?
FDC Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is FDC Ltd a good quality company?
FDC Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is FDC Ltd undervalued or overvalued?
FDC Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is FDC Ltd a good buy now?
FDC Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of FDC Ltd?
FDC Ltd revenue growth is 8% for FY-2025 , which is below its 5 year CAGR of 9.2% , indicating slower growth.
Q.2 Gross Profit margin of FDC Ltd?
FDC Ltd Gross profit margin which is the profit after deduction of direct costs, is 19.7% for FY-2025 , which is below its 5 year median of 20.6% , indicating decreasing margins.
Q.3 Operating Profit Margin of FDC Ltd?
FDC Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 15.47% for FY-2025 , which is below its 5 year median of 16.66% indicating decreasing margins.
Q.4 Net Profit Margin of FDC Ltd?
FDC Ltd Net Profit Margin is 13.22% for FY-2025 , is below with its 5 year median of 14.46%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 19.7 20.6
Operating Profit Margin 15.47 16.66
Net Profit Margin 13.22 14.46
Q.5 Return on Asset of FDC Ltd?
FDC Ltd Return on Asset is 7.88%, which is in line with its 5 year historical median of 7.88%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of FDC Ltd?
FDC Ltd Return on equity is 12.48% for FY-2025 , which is in line with its historical median of 12.48%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of FDC Ltd?
FDC Ltd Return on capital employed is 16.98% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 13.5%, indicating value creation.
Q.8 Cash conversion cycle of FDC Ltd?
FDC Ltd Cash conversion cycle is 40 days, below its historical median of 44 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.62 0.59
ROE 12.48 12.48
ROCE 16.98 16.98
Cash Conversion Cycle 40 days 44 days
Q.9 Debt to Equity ratio of FDC Ltd?
FDC Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of FDC Ltd?
FDC Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of FDC Ltd?
Promoters hold 69.66% of the FDC Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of FDC Ltd vs industry peers?
FDC Ltd revenue CAGR is 9.23% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 2,070.1 137.1
Gross Profit 407.8 15.1
Operating Profit 320 16
Net Profit 274 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.62 0.8
ROE 12.48 8.91
ROCE 16.98 11.59
Cash Conversion Cycle (days) 39.91 76

Valuation & price assessment

Q.1 Stock return of FDC Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 6.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 6.8% 2.8% 10.8% -16.6%
Q.3 Valuation ratios of FDC Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 25.53 19.68 40.28
Price to Book 2.35 3.44 2.77
Price to Sales 2.84 4.32 2.65
EV to EBITDA 14.85 13.54 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×